SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'DWZ'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1I2W_A_CFXA1300_1 (BETA-LACTAMASE) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 7 / 12 | SER A 84LYS A 87SER A 142GLU A 182THR A 232LYS A 250GLY A 252 | DWZ A 400 (-1.3A)DWZ A 400 (-2.6A)DWZ A 400 (-2.7A)DWZ A 400 (-2.8A)DWZ A 400 ( 4.5A)DWZ A 400 ( 3.8A)DWZ A 400 (-3.3A) | 0.35A | 1i2wA-3dwzA:41.5 | 1i2wA-3dwzA:44.37 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1I2W_B_CFXB2300_1 (BETA-LACTAMASE) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 6 / 12 | SER A 84LYS A 87SER A 142GLU A 182THR A 232GLY A 252 | DWZ A 400 (-1.3A)DWZ A 400 (-2.6A)DWZ A 400 (-2.7A)DWZ A 400 (-2.8A)DWZ A 400 ( 4.5A)DWZ A 400 (-3.3A) | 0.38A | 1i2wB-3dwzA:41.5 | 1i2wB-3dwzA:44.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1JR1_B_MOAB1333_1 (INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE 2) |
4zfq | L,D-TRANSPEPTIDASE 5 (Mycobacteriumtuberculosis) | 4 / 8 | ASN A 362GLY A 291THR A 300GLY A 338 | NoneNoneNoneDWZ A 503 (-2.8A) | 0.80A | 1jr1B-4zfqA:undetectable | 1jr1B-4zfqA:22.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YMX_A_CFXA1001_1 (BETA-LACTAMASECTX-M-9) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 10 / 12 | SER A 84LYS A 87SER A 142GLU A 182ASN A 186THR A 232LYS A 250GLY A 252GLY A 254ASP A 255 | DWZ A 400 (-1.3A)DWZ A 400 (-2.6A)DWZ A 400 (-2.7A)DWZ A 400 (-2.8A)DWZ A 400 ( 4.0A)DWZ A 400 ( 4.5A)DWZ A 400 ( 3.8A)DWZ A 400 (-3.3A)NoneNone | 0.58A | 1ymxA-3dwzA:41.2 | 1ymxA-3dwzA:45.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YMX_B_CFXB1002_1 (BETA-LACTAMASECTX-M-9) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 9 / 12 | SER A 84LYS A 87SER A 142GLU A 182ASN A 186LYS A 250GLY A 252GLY A 254ASP A 255 | DWZ A 400 (-1.3A)DWZ A 400 (-2.6A)DWZ A 400 (-2.7A)DWZ A 400 (-2.8A)DWZ A 400 ( 4.0A)DWZ A 400 ( 3.8A)DWZ A 400 (-3.3A)NoneNone | 0.50A | 1ymxB-3dwzA:41.3 | 1ymxB-3dwzA:45.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YMX_B_CFXB1002_2 (BETA-LACTAMASECTX-M-9) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 4 / 5 | CYH A 83PRO A 183THR A 232THR A 251 | DWZ A 400 (-4.9A)NoneDWZ A 400 ( 4.5A)DWZ A 400 (-3.5A) | 0.33A | 1ymxB-3dwzA:41.3 | 1ymxB-3dwzA:45.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2A1H_A_GBNA502_1 (BRANCHED CHAINAMINOTRANSFERASE) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 4 / 8 | TYR A 109GLY A 144THR A 145ALA A 146 | NoneDWZ A 400 ( 3.8A)NoneNone | 0.83A | 2a1hA-3dwzA:undetectable2a1hB-3dwzA:undetectable | 2a1hA-3dwzA:21.182a1hB-3dwzA:21.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HLW_A_CE3A301_1 (CTX-M-9EXTENDED-SPECTRUMBETA-LACTAMASE) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 7 / 12 | LYS A 87SER A 142ASN A 186THR A 232LYS A 250GLY A 252GLY A 254 | DWZ A 400 (-2.6A)DWZ A 400 (-2.7A)DWZ A 400 ( 4.0A)DWZ A 400 ( 4.5A)DWZ A 400 ( 3.8A)DWZ A 400 (-3.3A)None | 0.51A | 3hlwA-3dwzA:41.2 | 3hlwA-3dwzA:44.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HLW_A_CE3A301_2 (CTX-M-9EXTENDED-SPECTRUMBETA-LACTAMASE) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 4 / 4 | CYH A 83PRO A 183THR A 251ASP A 255 | DWZ A 400 (-4.9A)NoneDWZ A 400 (-3.5A)None | 0.88A | 3hlwA-3dwzA:41.2 | 3hlwA-3dwzA:44.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HLW_B_CE3B302_1 (CTX-M-9EXTENDED-SPECTRUMBETA-LACTAMASE) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 7 / 12 | SER A 142ASN A 186THR A 232LYS A 250THR A 251GLY A 252GLY A 254 | DWZ A 400 (-2.7A)DWZ A 400 ( 4.0A)DWZ A 400 ( 4.5A)DWZ A 400 ( 3.8A)DWZ A 400 (-3.5A)DWZ A 400 (-3.3A)None | 0.36A | 3hlwB-3dwzA:41.4 | 3hlwB-3dwzA:44.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HUO_A_PNNA300_0 (CTX-M-9EXTENDED-SPECTRUMBETA-LACTAMASE) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 8 / 12 | CYH A 83LYS A 87ASN A 186LYS A 250THR A 251GLY A 252GLY A 254ASP A 255 | DWZ A 400 (-4.9A)DWZ A 400 (-2.6A)DWZ A 400 ( 4.0A)DWZ A 400 ( 3.8A)DWZ A 400 (-3.5A)DWZ A 400 (-3.3A)NoneNone | 0.50A | 3huoA-3dwzA:41.3 | 3huoA-3dwzA:44.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HUO_B_PNNB301_0 (CTX-M-9EXTENDED-SPECTRUMBETA-LACTAMASE) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 7 / 12 | CYH A 83LYS A 87ASN A 186LYS A 250GLY A 252GLY A 254ASP A 255 | DWZ A 400 (-4.9A)DWZ A 400 (-2.6A)DWZ A 400 ( 4.0A)DWZ A 400 ( 3.8A)DWZ A 400 (-3.3A)NoneNone | 0.49A | 3huoB-3dwzA:41.3 | 3huoB-3dwzA:44.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3NY4_A_SMXA308_1 (BETA-LACTAMASE) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 12 / 12 | SER A 84ILE A 117SER A 142ASN A 186THR A 232ARG A 236LYS A 250THR A 251GLY A 252THR A 253GLY A 254ASP A 255 | DWZ A 400 (-1.3A)DWZ A 400 (-4.0A)DWZ A 400 (-2.7A)DWZ A 400 ( 4.0A)DWZ A 400 ( 4.5A)DWZ A 400 ( 4.3A)DWZ A 400 ( 3.8A)DWZ A 400 (-3.5A)DWZ A 400 (-3.3A)DWZ A 400 (-4.1A)NoneNone | 0.37A | 3ny4A-3dwzA:49.6 | 3ny4A-3dwzA:99.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3NY4_A_SMXA309_1 (BETA-LACTAMASE) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 5 / 5 | ILE A 117ARG A 236THR A 253GLU A 289GLU A 292 | DWZ A 400 (-4.0A)DWZ A 400 ( 4.3A)DWZ A 400 (-4.1A)NoneNone | 0.62A | 3ny4A-3dwzA:49.6 | 3ny4A-3dwzA:99.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 7 / 12 | LYS A 87SER A 142ASN A 186LYS A 250GLY A 252GLY A 254ASP A 255 | DWZ A 400 (-2.6A)DWZ A 400 (-2.7A)DWZ A 400 ( 4.0A)DWZ A 400 ( 3.8A)DWZ A 400 (-3.3A)NoneNone | 0.51A | 3q07A-3dwzA:41.3 | 3q07A-3dwzA:44.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 7 / 12 | LYS A 87SER A 142ASN A 186LYS A 250GLY A 252GLY A 254ASP A 255 | DWZ A 400 (-2.6A)DWZ A 400 (-2.7A)DWZ A 400 ( 4.0A)DWZ A 400 ( 3.8A)DWZ A 400 (-3.3A)NoneNone | 0.58A | 3q07B-3dwzA:41.5 | 3q07B-3dwzA:44.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4EUZ_A_MEMA401_1 (CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 8 / 12 | LYS A 87SER A 142ASN A 186THR A 232LYS A 250THR A 251GLY A 252THR A 253 | DWZ A 400 (-2.6A)DWZ A 400 (-2.7A)DWZ A 400 ( 4.0A)DWZ A 400 ( 4.5A)DWZ A 400 ( 3.8A)DWZ A 400 (-3.5A)DWZ A 400 (-3.3A)DWZ A 400 (-4.1A) | 0.35A | 4euzA-3dwzA:39.7 | 4euzA-3dwzA:43.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FO4_B_MOAB502_1 (INOSINE5'-MONOPHOSPHATEDEHYDROGENASE) |
4zfq | L,D-TRANSPEPTIDASE 5 (Mycobacteriumtuberculosis) | 4 / 8 | ASN A 362GLY A 291THR A 300GLY A 338 | NoneNoneNoneDWZ A 503 (-2.8A) | 0.75A | 4fo4B-4zfqA:undetectable | 4fo4B-4zfqA:24.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4N9K_A_CEDA301_1 (BETA-LACTAMASE) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 6 / 12 | SER A 84SER A 142ASN A 186LYS A 250THR A 251GLY A 252 | DWZ A 400 (-1.3A)DWZ A 400 (-2.7A)DWZ A 400 ( 4.0A)DWZ A 400 ( 3.8A)DWZ A 400 (-3.5A)DWZ A 400 (-3.3A) | 0.20A | 4n9kA-3dwzA:41.8 | 4n9kA-3dwzA:45.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4N9K_B_CEDB301_1 (BETA-LACTAMASE) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 6 / 12 | SER A 84SER A 142ASN A 186LYS A 250THR A 251GLY A 252 | DWZ A 400 (-1.3A)DWZ A 400 (-2.7A)DWZ A 400 ( 4.0A)DWZ A 400 ( 3.8A)DWZ A 400 (-3.5A)DWZ A 400 (-3.3A) | 0.20A | 4n9kB-3dwzA:41.7 | 4n9kB-3dwzA:45.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4PM5_A_CE3A301_1 (BETA-LACTAMASECTX-M-14) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 6 / 12 | ASN A 186THR A 232LYS A 250THR A 251GLY A 252GLY A 254 | DWZ A 400 ( 4.0A)DWZ A 400 ( 4.5A)DWZ A 400 ( 3.8A)DWZ A 400 (-3.5A)DWZ A 400 (-3.3A)None | 0.34A | 4pm5A-3dwzA:41.1 | 4pm5A-3dwzA:45.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4PM5_A_CE3A301_1 (BETA-LACTAMASECTX-M-14) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 6 / 12 | SER A 142ASN A 186LYS A 250THR A 251GLY A 252GLY A 254 | DWZ A 400 (-2.7A)DWZ A 400 ( 4.0A)DWZ A 400 ( 3.8A)DWZ A 400 (-3.5A)DWZ A 400 (-3.3A)None | 0.62A | 4pm5A-3dwzA:41.1 | 4pm5A-3dwzA:45.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4PM5_A_CE3A301_2 (BETA-LACTAMASECTX-M-14) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 3 / 3 | CYH A 83PRO A 183ASP A 255 | DWZ A 400 (-4.9A)NoneNone | 0.82A | 4pm5A-3dwzA:41.1 | 4pm5A-3dwzA:45.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4PM7_A_CE3A301_1 (BETA-LACTAMASECTX-M-14) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 6 / 12 | LYS A 87ASN A 186THR A 232LYS A 250GLY A 252GLY A 254 | DWZ A 400 (-2.6A)DWZ A 400 ( 4.0A)DWZ A 400 ( 4.5A)DWZ A 400 ( 3.8A)DWZ A 400 (-3.3A)None | 0.51A | 4pm7A-3dwzA:41.0 | 4pm7A-3dwzA:45.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4PM7_A_CE3A301_1 (BETA-LACTAMASECTX-M-14) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 6 / 12 | LYS A 87SER A 142ASN A 186LYS A 250GLY A 252GLY A 254 | DWZ A 400 (-2.6A)DWZ A 400 (-2.7A)DWZ A 400 ( 4.0A)DWZ A 400 ( 3.8A)DWZ A 400 (-3.3A)None | 0.78A | 4pm7A-3dwzA:41.0 | 4pm7A-3dwzA:45.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4PM7_A_CE3A301_2 (BETA-LACTAMASECTX-M-14) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 4 / 4 | CYH A 83PRO A 183THR A 251ASP A 255 | DWZ A 400 (-4.9A)NoneDWZ A 400 (-3.5A)None | 0.76A | 4pm7A-3dwzA:41.0 | 4pm7A-3dwzA:45.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4PM9_A_CE3A301_1 (BETA-LACTAMASECTX-M-14) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 6 / 12 | ASN A 186THR A 232LYS A 250THR A 251GLY A 252GLY A 254 | DWZ A 400 ( 4.0A)DWZ A 400 ( 4.5A)DWZ A 400 ( 3.8A)DWZ A 400 (-3.5A)DWZ A 400 (-3.3A)None | 0.31A | 4pm9A-3dwzA:41.4 | 4pm9A-3dwzA:45.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4PM9_A_CE3A301_1 (BETA-LACTAMASECTX-M-14) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 6 / 12 | SER A 142ASN A 186LYS A 250THR A 251GLY A 252GLY A 254 | DWZ A 400 (-2.7A)DWZ A 400 ( 4.0A)DWZ A 400 ( 3.8A)DWZ A 400 (-3.5A)DWZ A 400 (-3.3A)None | 0.61A | 4pm9A-3dwzA:41.4 | 4pm9A-3dwzA:45.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5GHY_A_CEDA301_1 (BETA-LACTAMASE) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 5 / 12 | SER A 84SER A 142ASN A 186LYS A 250GLY A 252 | DWZ A 400 (-1.3A)DWZ A 400 (-2.7A)DWZ A 400 ( 4.0A)DWZ A 400 ( 3.8A)DWZ A 400 (-3.3A) | 0.22A | 5ghyA-3dwzA:41.8 | 5ghyA-3dwzA:45.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5GHY_B_CEDB301_1 (BETA-LACTAMASE) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 5 / 12 | SER A 84SER A 142ASN A 186LYS A 250GLY A 252 | DWZ A 400 (-1.3A)DWZ A 400 (-2.7A)DWZ A 400 ( 4.0A)DWZ A 400 ( 3.8A)DWZ A 400 (-3.3A) | 0.23A | 5ghyB-3dwzA:41.8 | 5ghyB-3dwzA:45.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5GHZ_A_CEDA301_1 (BETA-LACTAMASE) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 6 / 11 | SER A 84SER A 142ASN A 186LYS A 250THR A 251GLY A 252 | DWZ A 400 (-1.3A)DWZ A 400 (-2.7A)DWZ A 400 ( 4.0A)DWZ A 400 ( 3.8A)DWZ A 400 (-3.5A)DWZ A 400 (-3.3A) | 0.22A | 5ghzA-3dwzA:41.7 | 5ghzA-3dwzA:45.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5GHZ_B_CEDB301_1 (BETA-LACTAMASE) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 6 / 10 | SER A 84SER A 142ASN A 186LYS A 250THR A 251GLY A 252 | DWZ A 400 (-1.3A)DWZ A 400 (-2.7A)DWZ A 400 ( 4.0A)DWZ A 400 ( 3.8A)DWZ A 400 (-3.5A)DWZ A 400 (-3.3A) | 0.20A | 5ghzB-3dwzA:41.7 | 5ghzB-3dwzA:45.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5YVN_A_ACTA305_0 (GLUTATHIONES-TRANSFERASEOMEGA-1) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 4 / 6 | LEU A 185LYS A 87LEU A 90LEU A 151 | NoneDWZ A 400 (-2.6A)NoneNone | 1.11A | 5yvnA-3dwzA:undetectable | 5yvnA-3dwzA:20.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6B5Y_A_9F2A302_1 (BETA-LACTAMASE) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 6 / 9 | ILE A 117PRO A 119TYR A 141THR A 231THR A 232ASP A 255 | DWZ A 400 (-4.0A)DWZ A 400 ( 4.5A)NoneNoneDWZ A 400 ( 4.5A)None | 0.63A | 6b5yA-3dwzA:48.26b5yB-3dwzA:48.2 | 6b5yA-3dwzA:100.006b5yB-3dwzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6B5Y_B_9F2B400_1 (BETA-LACTAMASE) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 12 / 12 | CYH A 83SER A 84SER A 142ASN A 186THR A 232ARG A 236LYS A 250THR A 251GLY A 252THR A 253GLY A 254ASP A 255 | DWZ A 400 (-4.9A)DWZ A 400 (-1.3A)DWZ A 400 (-2.7A)DWZ A 400 ( 4.0A)DWZ A 400 ( 4.5A)DWZ A 400 ( 4.3A)DWZ A 400 ( 3.8A)DWZ A 400 (-3.5A)DWZ A 400 (-3.3A)DWZ A 400 (-4.1A)NoneNone | 0.36A | 6b5yB-3dwzA:48.2 | 6b5yB-3dwzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6B5Y_C_9F2C302_1 (BETA-LACTAMASE) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 5 / 10 | ILE A 117PRO A 119TYR A 141THR A 231ASP A 255 | DWZ A 400 (-4.0A)DWZ A 400 ( 4.5A)NoneNoneNone | 0.80A | 6b5yC-3dwzA:48.16b5yD-3dwzA:48.3 | 6b5yC-3dwzA:100.006b5yD-3dwzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6B5Y_C_9F2C302_1 (BETA-LACTAMASE) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 5 / 10 | PRO A 119TYR A 141THR A 231THR A 232ASP A 255 | DWZ A 400 ( 4.5A)NoneNoneDWZ A 400 ( 4.5A)None | 0.34A | 6b5yC-3dwzA:48.16b5yD-3dwzA:48.3 | 6b5yC-3dwzA:100.006b5yD-3dwzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6B5Y_D_9F2D400_1 (BETA-LACTAMASE) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 12 / 12 | CYH A 83SER A 84SER A 142ASN A 186THR A 232LYS A 250THR A 251GLY A 252THR A 253GLY A 254ASP A 255GLU A 292 | DWZ A 400 (-4.9A)DWZ A 400 (-1.3A)DWZ A 400 (-2.7A)DWZ A 400 ( 4.0A)DWZ A 400 ( 4.5A)DWZ A 400 ( 3.8A)DWZ A 400 (-3.5A)DWZ A 400 (-3.3A)DWZ A 400 (-4.1A)NoneNoneNone | 0.38A | 6b5yD-3dwzA:48.3 | 6b5yD-3dwzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6B68_A_9F2A302_1 (BETA-LACTAMASE) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 6 / 9 | ILE A 117PRO A 119TYR A 141THR A 231THR A 232ASP A 255 | DWZ A 400 (-4.0A)DWZ A 400 ( 4.5A)NoneNoneDWZ A 400 ( 4.5A)None | 0.64A | 6b68A-3dwzA:48.56b68B-3dwzA:48.6 | 6b68A-3dwzA:100.006b68B-3dwzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6B68_B_9F2B301_1 (BETA-LACTAMASE) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 12 / 12 | CYH A 83SER A 84SER A 142ASN A 186ARG A 187THR A 232LYS A 250THR A 251GLY A 252THR A 253GLY A 254ASP A 255 | DWZ A 400 (-4.9A)DWZ A 400 (-1.3A)DWZ A 400 (-2.7A)DWZ A 400 ( 4.0A)NoneDWZ A 400 ( 4.5A)DWZ A 400 ( 3.8A)DWZ A 400 (-3.5A)DWZ A 400 (-3.3A)DWZ A 400 (-4.1A)NoneNone | 0.34A | 6b68B-3dwzA:48.6 | 6b68B-3dwzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6B68_C_9F2C302_1 (BETA-LACTAMASE) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 6 / 10 | ILE A 117PRO A 119TYR A 141THR A 231THR A 232ASP A 255 | DWZ A 400 (-4.0A)DWZ A 400 ( 4.5A)NoneNoneDWZ A 400 ( 4.5A)None | 0.65A | 6b68C-3dwzA:48.46b68D-3dwzA:48.5 | 6b68C-3dwzA:100.006b68D-3dwzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6B68_D_9F2D400_1 (BETA-LACTAMASE) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 11 / 12 | SER A 84SER A 142ASN A 186THR A 232ARG A 236LYS A 250GLY A 252THR A 253GLY A 254ASP A 255GLU A 292 | DWZ A 400 (-1.3A)DWZ A 400 (-2.7A)DWZ A 400 ( 4.0A)DWZ A 400 ( 4.5A)DWZ A 400 ( 4.3A)DWZ A 400 ( 3.8A)DWZ A 400 (-3.3A)DWZ A 400 (-4.1A)NoneNoneNone | 0.33A | 6b68D-3dwzA:48.5 | 6b68D-3dwzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6B69_A_9F2A302_1 (BETA-LACTAMASE) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 6 / 9 | ILE A 117PRO A 119TYR A 141THR A 231THR A 232ASP A 255 | DWZ A 400 (-4.0A)DWZ A 400 ( 4.5A)NoneNoneDWZ A 400 ( 4.5A)None | 0.60A | 6b69A-3dwzA:48.56b69B-3dwzA:48.4 | 6b69A-3dwzA:100.006b69B-3dwzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6B69_B_9F2B301_1 (BETA-LACTAMASE) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 11 / 12 | SER A 84SER A 142PRO A 183ASN A 186THR A 232LYS A 250THR A 251GLY A 252THR A 253GLY A 254ASP A 255 | DWZ A 400 (-1.3A)DWZ A 400 (-2.7A)NoneDWZ A 400 ( 4.0A)DWZ A 400 ( 4.5A)DWZ A 400 ( 3.8A)DWZ A 400 (-3.5A)DWZ A 400 (-3.3A)DWZ A 400 (-4.1A)NoneNone | 0.34A | 6b69A-3dwzA:48.56b69B-3dwzA:48.4 | 6b69A-3dwzA:100.006b69B-3dwzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6B69_C_9F2C302_1 (BETA-LACTAMASE) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 6 / 9 | ILE A 117PRO A 119TYR A 141THR A 231THR A 232ASP A 255 | DWZ A 400 (-4.0A)DWZ A 400 ( 4.5A)NoneNoneDWZ A 400 ( 4.5A)None | 0.59A | 6b69C-3dwzA:48.56b69D-3dwzA:48.3 | 6b69C-3dwzA:100.006b69D-3dwzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6B69_D_9F2D301_1 (BETA-LACTAMASE) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 12 / 12 | CYH A 83SER A 84SER A 142ASN A 186THR A 232ARG A 236LYS A 250THR A 251GLY A 252THR A 253GLY A 254GLU A 292 | DWZ A 400 (-4.9A)DWZ A 400 (-1.3A)DWZ A 400 (-2.7A)DWZ A 400 ( 4.0A)DWZ A 400 ( 4.5A)DWZ A 400 ( 4.3A)DWZ A 400 ( 3.8A)DWZ A 400 (-3.5A)DWZ A 400 (-3.3A)DWZ A 400 (-4.1A)NoneNone | 0.24A | 6b69D-3dwzA:48.3 | 6b69D-3dwzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6B6A_A_9F2A302_1 (BETA-LACTAMASE) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 6 / 9 | ILE A 117PRO A 119TYR A 141THR A 231THR A 232ASP A 255 | DWZ A 400 (-4.0A)DWZ A 400 ( 4.5A)NoneNoneDWZ A 400 ( 4.5A)None | 0.50A | 6b6aA-3dwzA:47.86b6aB-3dwzA:48.2 | 6b6aA-3dwzA:100.006b6aB-3dwzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6B6A_B_9F2B301_1 (BETA-LACTAMASE) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 12 / 12 | CYH A 83SER A 84SER A 142ASN A 186THR A 232ARG A 236LYS A 250THR A 251GLY A 252THR A 253GLY A 254ASP A 255 | DWZ A 400 (-4.9A)DWZ A 400 (-1.3A)DWZ A 400 (-2.7A)DWZ A 400 ( 4.0A)DWZ A 400 ( 4.5A)DWZ A 400 ( 4.3A)DWZ A 400 ( 3.8A)DWZ A 400 (-3.5A)DWZ A 400 (-3.3A)DWZ A 400 (-4.1A)NoneNone | 0.27A | 6b6aB-3dwzA:48.2 | 6b6aB-3dwzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6B6A_C_9F2C302_1 (BETA-LACTAMASE) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 6 / 9 | ILE A 117PRO A 119TYR A 141THR A 231THR A 232ASP A 255 | DWZ A 400 (-4.0A)DWZ A 400 ( 4.5A)NoneNoneDWZ A 400 ( 4.5A)None | 0.39A | 6b6aC-3dwzA:47.86b6aD-3dwzA:48.0 | 6b6aC-3dwzA:100.006b6aD-3dwzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6B6A_D_9F2D301_1 (BETA-LACTAMASE) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 12 / 12 | SER A 84ILE A 117SER A 142ASN A 186ARG A 236LYS A 250THR A 251GLY A 252THR A 253GLY A 254ASP A 255GLU A 292 | DWZ A 400 (-1.3A)DWZ A 400 (-4.0A)DWZ A 400 (-2.7A)DWZ A 400 ( 4.0A)DWZ A 400 ( 4.3A)DWZ A 400 ( 3.8A)DWZ A 400 (-3.5A)DWZ A 400 (-3.3A)DWZ A 400 (-4.1A)NoneNoneNone | 0.39A | 6b6aD-3dwzA:48.0 | 6b6aD-3dwzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6B6C_A_9F2A301_1 (BETA-LACTAMASE) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 12 / 12 | SER A 84ILE A 117SER A 142PRO A 183ASN A 186ARG A 187ARG A 236LYS A 250THR A 251GLY A 252THR A 253GLY A 254 | DWZ A 400 (-1.3A)DWZ A 400 (-4.0A)DWZ A 400 (-2.7A)NoneDWZ A 400 ( 4.0A)NoneDWZ A 400 ( 4.3A)DWZ A 400 ( 3.8A)DWZ A 400 (-3.5A)DWZ A 400 (-3.3A)DWZ A 400 (-4.1A)None | 0.44A | 6b6cA-3dwzA:47.1 | 6b6cA-3dwzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6B6D_A_9F2A302_1 (BETA-LACTAMASE) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 12 / 12 | CYH A 83SER A 84ILE A 117SER A 142ASN A 186ARG A 187THR A 232LYS A 250THR A 251GLY A 252THR A 253GLY A 254 | DWZ A 400 (-4.9A)DWZ A 400 (-1.3A)DWZ A 400 (-4.0A)DWZ A 400 (-2.7A)DWZ A 400 ( 4.0A)NoneDWZ A 400 ( 4.5A)DWZ A 400 ( 3.8A)DWZ A 400 (-3.5A)DWZ A 400 (-3.3A)DWZ A 400 (-4.1A)None | 0.60A | 6b6dA-3dwzA:46.6 | 6b6dA-3dwzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6B6E_A_9F2A302_1 (BETA-LACTAMASE) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 12 / 12 | SER A 84ILE A 117SER A 142ASN A 186ARG A 187THR A 232ARG A 236LYS A 250THR A 251GLY A 252THR A 253GLY A 254 | DWZ A 400 (-1.3A)DWZ A 400 (-4.0A)DWZ A 400 (-2.7A)DWZ A 400 ( 4.0A)NoneDWZ A 400 ( 4.5A)DWZ A 400 ( 4.3A)DWZ A 400 ( 3.8A)DWZ A 400 (-3.5A)DWZ A 400 (-3.3A)DWZ A 400 (-4.1A)None | 0.37A | 6b6eA-3dwzA:47.0 | 6b6eA-3dwzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6B6F_A_9F2A301_1 (BETA-LACTAMASE) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 12 / 12 | CYH A 83SER A 84ILE A 117SER A 142PRO A 183ASN A 186LYS A 250THR A 251GLY A 252THR A 253GLY A 254ASP A 255 | DWZ A 400 (-4.9A)DWZ A 400 (-1.3A)DWZ A 400 (-4.0A)DWZ A 400 (-2.7A)NoneDWZ A 400 ( 4.0A)DWZ A 400 ( 3.8A)DWZ A 400 (-3.5A)DWZ A 400 (-3.3A)DWZ A 400 (-4.1A)NoneNone | 0.51A | 6b6fA-3dwzA:46.7 | 6b6fA-3dwzA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6C79_A_CE3A301_1 (BETA-LACTAMASETOHO-1) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 6 / 12 | SER A 142ASN A 186THR A 232LYS A 250GLY A 252GLY A 254 | DWZ A 400 (-2.7A)DWZ A 400 ( 4.0A)DWZ A 400 ( 4.5A)DWZ A 400 ( 3.8A)DWZ A 400 (-3.3A)None | 0.38A | 6c79A-3dwzA:41.5 | 6c79A-3dwzA:20.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6C79_A_CE3A301_2 (BETA-LACTAMASETOHO-1) |
3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) | 4 / 4 | CYH A 83PRO A 183THR A 251ASP A 255 | DWZ A 400 (-4.9A)NoneDWZ A 400 (-3.5A)None | 0.80A | 6c79A-3dwzA:41.5 | 6c79A-3dwzA:20.57 |